Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Probably similar to a lot of other holders who got in around the 8p range, currently sitting on a 79% paper loss. You've lost so much already it's hardly worth realizing your loss, he'll stick with it as the only thing left now is hope.
James Robert Kight hasn't disclosed any purchase or sale of his holding since April 2022 which could be read several ways.
If he's still positive on Evgen he could be waiting to provide funding in any future raise if required which could be seen as positive for shareholders.
If he's not positive on Evgens prospects or happy with last Decembers options grab by BOD who refrain from investing any of their own funds why hasn't he sold any of his 33.1M shares?
Well it’s been over two months since any news, there must be some news soon. But I think only news which involves money being received can help the share price here because the money is running out fast.
We are bound to get a temporary spike sooner or later.
Tradebot summary today
EVG closed down 2.78 percent on Tuesday, October 17, 2023, on 69 percent of normal volume. The bears made the stock sink to a new 52-week low. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.
If I were running a business and my share holders were suffering I would be now have a financial vested interest just so I could be seen to be sharing the pain. I wouldn't expect to give out a running daily commentary, but some news with progress or lack of it should be a minimum. Clearly the current bods have no experience of running a business, rabbits in headlights comes to mind.
CJ39 my current position even though it's very small is based on the bods having some integrity, I could be completely wrong and my initial assessment that they are a bunch of charlatans could be more apt. That being the case they won't even bother with a share dilution, they'll just milk the company dry and then shut up shop around this time next year. Huw has a track record of being a director of failed companies. I really think they would struggle to raise new funds as things stand and as you said, it will severely dilute existing shareholders value at these levels.
You may well ask why I've gone in again, apart from the technical analysis 3.02 gap, most holders have lost so much, they won't be selling at these levels so the share price should stabilise.
Yep. I agree with you.
Oh and don’t get me started on their comments that they aren’t allowed to buy shares for legal reasons. They are treating shareholders as mugs. Just tell us “this is a turkey, it’s just not going to make any money for donkeys years”.
Depends what the news is. They need money desperately because it’s running out fast and they have no sources of income other than Stalicla payments but they are so vague, it was first said $6m would be received by the end of 2023 but that changed without any information given to as anticipated by the end of 2024’. So poor, I bought in believing the money would be received this year to keep the company funded a year longer.
Funny thing is, those who still believe in EVG believe everything EVG say and believe the money is coming.
We never even heard the real reason Juvenesense pulled out. It’s just really poor how they try to keep shareholders in the dark as if we don’t need to know this stuff.
You are not going to get a gap fill at 3.02p from here without positive news, Kingalf. Certainly not in this type of market.
But then IMO positive news that means you do get your target price, will also likely see a SP higher than that still.
Which would be no thanks to the BOD here, quite frankly. GLA.
It's certainly pitch black as things stand.
Where is K3VMC who was giving it large back in August, buying what appeared to be £4000 worth of shares at around 2.55p and slaughtering Alf and myself for our criticism of the share. He’s got to be feeling a bit disappointed with how the share price has dropped by about 30% since then and disappointed by his conduct on here.
Well those that listened are greatful as they have minimised their losses. As I said yesterday I'm expecting a small bounce to fill the gap at 3.02p and then I'm out. I'm definitely not encouraging anyone else to buy, or harping on about what a great prospect it is. Short term position to take advantage of it being oversold
Shades of DMTR here. Avoid like the plague.
So Alf is buying whilst telling everyone else every day, sometimes several times a day, not to buy! 😅
Cheers again alf you save me a nice few quid
Even lower today, 1.849 offer for 10k.
Huw clearly has Viking heritage, he and his fellow board members have definitely pillaged Evgen. The ratio of input (salaries) to output (share price) is boardering on the criminal in my eyes. Still they can't buy for legal reasons, can't wait to see what that advice was and who gave it to them
it will be interesting to see what excuse the bods come up with for not buying during the next q&a.
more than happy to take their extortionate salaries but give back nothing. aim directors at their worst. as a share holder i can now justifiable **** them off.
I can see your trade, 1.86p to buy, how quickly this has fallen. I don’t fancy this share at all now. If they released some transformational news which advised a large amount of money had been paid to EVG I could change my mind.
I'm expecting some kind of bounce so have just purchased 20k shares as a short term position.
Actually the placeing in August was at a premium to the share price, The shares were trading at around 11p and the issue was at 12p.
One the bods owns a company that has at 14% stake in the company. Clearly they knew they were onto something hence the premium and bods having skin in the game.
Ralf, nothing wrong with that suggestion imo.
However anyone invested in OBD for several years may have sat on paper losses continually averaging down which appears to be the case for it's largest holder of shares...
OBD is an interesting case study (well recent events) August saw a placing and primary bid which presumably allowed ii's to average down as well as pi's..
I agree with you that the BOD not buying even at these low levels isn't a great signal and Hugh suggesting they have been advised they cannot doesn't seem right.
For me there's a lot of potential here but that has to materialise.
Just like Oxford Bio this week, why go through all the pain when you can just join the party as it gets going
Ralf, are you looking at the right Stalicla ? ;-)
DEPI Technology
STALICLA’s precision medicine approach begins with ‘endophenotyping’—identifying the nonbehavioral physical and molecular presentations of NDDs and characterizing subgroups of patients with similar disease signatures.
DEPI matches these patient subgroups with an NDD-targeted drug (or drug combination) by integrating and analyzing large omics data sets, including genomics, proteomics, pharmacogenomics and clinical data.
Once a drug or drug combination is identified as a potential candidate, STALICLA validates its approach through clinical and laboratory studies using patient cells.
http://stalicla.com/approach
Stalicla have their fingers in lots of pies. Similar to Evgen trying to apply their product to lots of different areas hoping one works. Four areas of concern
1. They've pretty much done the same thing they did with Juv, keep moving the payment date forward with no explanation.
2. Still no bod participation. There was absolutely no reason for them not to buy in on the last share dilution but they chose not to. Happy to encourage everyone else to do so though
3. Huws shocking track record as a company director. Just look him up on company house.
4. A share placement in the spring will further dilute shareholder value.
All doesn't bode well in my eyes.